Trial reportJournal of neuroengineering and rehabilitation2026
Efficacy and hematological markers of tDCS combined with aerobic exercise in improving executive function in patients with PSCI.
Trial report in Journal of neuroengineering and rehabilitation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveThis study investigated the effects of combined transcranial direct current stimulation (tDCS) and aerobic exercise (AE) on executive function and hematological markers in poststroke cognitive impairment (PSCI) patients.
methodsA total of 74 PSCI patients were randomly assigned to three groups: the tDCS + AE, tDCS, and AE groups. The tDCS group received 2.0 mA anodal stimulation over the left dorsolateral prefrontal cortex (DLPFC) for 30 min, five days per week for four weeks. The AE group performed moderate-intensity exercise (60-70% HRmax) for 30 min with sham tDCS. The combined group received both interventions concurrently. Executive function was assessed using C-EXIT25, the Stroop test, the 1-back task, and word recall tests. Emotional state was evaluated with the Hamilton Depression Rating Scale (HAMD) and the Hamilton Anxiety Rating Scale (HAMA). Serum biomarkers were analyzed pre- and postintervention. Statistical analyses included repeated measures ANOVA and Spearman correlation with Bonferroni correction.
resultsExecutive function significantly improved in the combined group, with lower C-EXIT25 scores, faster Stroop congruent reaction times, and fewer word recall errors compared to the tDCS and AE groups. HAMD scores significantly decreased in the combined group. BDNF, NGF, DA, GABA, 5-HT, and ACh levels increased postintervention, whereas the level of Glu decreased in the combined group. An increase in BDNF correlated with faster Stroop response times, and an increase in NGF correlated with improvements in MMSE scores.
conclusiontDCS combined with AE significantly enhanced executive function in PSCI patients. These benefits were associated with increased neurotrophic factor levels, supporting a central-peripheral integrative rehabilitation approach for PSCI treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.